LRMR icon

Larimar Therapeutics

81 hedge funds and large institutions have $43.4M invested in Larimar Therapeutics in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

0% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 23

4% less capital invested

Capital invested by funds: $45.4M → $43.4M (-$1.96M)

72% less call options, than puts

Call options by funds: $140K | Put options by funds: $495K

Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$140K
Puts
$495K
Net Calls
Net Calls Change

Top Buyers

1 +$1.91M
2 +$1.59M
3 +$986K
4
Millennium Management
Millennium Management
New York
+$844K
5
PP
Paloma Partners
Connecticut
+$352K

Top Sellers

1 -$1.99M
2 -$1.59M
3 -$878K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$762K
5
Northern Trust
Northern Trust
Illinois
-$468K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$12.9M
2
$2.32M
3
$2.27M
4
$2.11M
5
$1.91M
6
$1.6M
7
$1.59M
8
$1.59M
9
$1.49M
10
$1.44M
11
$1.16M
12
$1.12M
13
$1.12M
14
$986K
15
$975K
16
$861K
17
$726K
18
$540K
19
$457K
20
$420K
21
$412K
22
$383K
23
$362K
24
$352K
25
$343K